Press Releases Cognition Therapeutics, Inc.

Equities

CGTX

US19243B1026

Market Closed - Nasdaq Other stock markets 01:30:00 27/06/2024 am IST			5-day change	1st Jan Change
1.7 ^USD	-3.41%		-15.42%	-8.11%

07/06	Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target	MT
29/05	HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cognition Therapeutics : CGTX Corporate Deck	13/06	PU
Cognition Therapeutics Releases New Episode of “Conversations” Podcast: Protecting the Synapse from Amyloid Toxicity in Alzheimer's Disease	21/05	AQ
Cognition Therapeutics Reports Financial Results for the First Quarter 2024 and Provides Business Update	07/05	GL
Cognition Therapeutics Completes Enrollment in Phase 2 SHIMMER Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies	29/04	AQ
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer's disease	23/04	AQ
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease	22/04	AQ
Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference	02/04	GL
Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer’s Disease on April 12, 2024	01/04	AQ
Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update	26/03	GL
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results	15/03	GL
Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results	15/03	AQ
Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock	15/03	GL
Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock	12/03	GL
Cognition Therapeutics : Results of Operations and Financial Condition - Form 8-K	12/03	PU
Cognition Therapeutics Announces Proposed Public Offering of Common Stock	12/03	GL
Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer’s Disease Studies	06/03	AQ
Cognition Therapeutics to Present at the TD Cowen Health Care Conference	26/02	GL
Cognition Therapeutics to Present at the TD Cowen Health Care Conference	26/02	AQ
New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812	06/02	AQ
Cognition Therapeutics CEO Issues Letter to Shareholders	04/01	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cognition Therapeutics, Inc.

Equities

CGTX

US19243B1026

Press Releases

Filters